Koren-Michowitz, M., Gery, S., Tabayashi, T., Lin, D., Alvarez, R., Nagler, A., & Koeffler, H. P. (2013). SH2B3 (LNK) mutations from Myeloproliferative Neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Koren-Michowitz, Maya, Sigal Gery, Takayuki Tabayashi, Dechen Lin, Rocio Alvarez, Arnon Nagler, and H. Phillip Koeffler. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.

Koren-Michowitz, Maya, et al. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.